Search Results - "Hameed, Rumaisa"

The current state of molecular profiling in gastrointestinal malignancies by Mukherji, Reetu, Yin, Chao, Hameed, Rumaisa, Alqahtani, Ali Z, Kulasekaran, Monika, He, Aiwu R, Weinberg, Benjamin A, Marshall, John L, Hartley, Marion L, Noel, Marcus S

“…This is a review of the current state of molecular profiling in gastrointestinal (GI) cancers and what to expect from this evolving field in the future…”
Get full text

DA-EPOCH-R Has Comparable Outcomes in De Novo and Transformed Diffuse Large B Cell Lymphoma by Desai, Sanjal H, Chaturvedi, Mansi, Hameed, Rumaisa, Baez Sosa, Valentina, Shenoy, Aarthi

“…Introduction It is increasingly recognized that transformed (T) diffuse large B cell lymphoma (DLBCL) is a clinically and biologically distinct entity from de…”
Get full text

Continuous maintenance (Maint) capecitabine (Cape) dosing for colorectal (CRC) and pancreatic cancers (PC): A single-institution, retrospective, real-world study by Mukherji, Reetu, Yin, Chao, Weinberg, Benjamin Adam, Alqahtani, Ali, Hameed, Rumaisa, Barcellos, Anna, Connole, Maegan, Perelgut, Chelsea, Fortuin, Josephine, Marshall, John

“…789 Background: Cape is an oral fluoropyrimidine (FP) used as maint therapy in CRC and PC. While the standard FDA dosing is 1250 mg/m 2 twice daily (BID) for…”
Get full text

Single‐Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B‐Cell Lymphoma by Desai, Sanjal, Chaturvedi, Mansi, Hameed, Rumaisa, Baez‐sosa, Valentina, Shenoy, Aarthi G.

“…Outcomes of diffuse large B‐cell lymphoma (DLBCL), either concurrent with or transformed from indolent lymphoma, treated with rituximab, cyclophosphamide,…”
Get full text

Biomarkers for immune therapy in gastrointestinal cancers by Weinberg, Benjamin A, Hameed, Rumaisa, Marshall, John L

“…Immunotherapy with checkpoint blockade of pro-grammed death 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) has substantially increased the…”
Get full text

Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma by Desai, Sanjal H., Baez-Sosa, Valentina, Hameed, Rumaisa, Al-Shbool, Ghassan, Fernandez, Stephen, Vakiti, Anusha, Stingo, Facundo, Adhikari, Tripti, Paku, Emily, Malkovska, Vera, Fishbein, Dawn

“…Improved hepatitis C virus (HCV) clearance due to directly acting antiviral agents has led to remarkably improved outcomes of indolent HCV-associated…”
Get full text